MedTrace Logo

Allergic Bronchopulmonary Aspergillosis Prescreening Study

NCT05903612 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-01-16

No results posted yet for this study

Summary

This prescreening study is being conducted to diagnose ABPA in selected patients with asthma and to increase the potential number of eligible participants for the ongoing Study 601-0018 of PUR1900 in subjects with ABPA. See: NCT05667662.

Additionally, this prescreening study may provide information that could assist the conduct of future studies conducted by Pulmatrix.

Conditions

  • Allergic Bronchopulmonary Aspergillosis
  • Asthma
  • ABPA

Sponsors & Collaborators

  • Pulmatrix Inc.

    collaborator INDUSTRY

  • Community Pharmacology Services Ltd

    lead OTHER

Principal Investigators

  • Margaret Wasilewski, MD · Pulmatrix Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-01-10
Completion
2024-01-10

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05903612 on ClinicalTrials.gov